{"id":792316,"date":"2024-12-04T08:13:47","date_gmt":"2024-12-04T13:13:47","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\/"},"modified":"2024-12-04T08:13:47","modified_gmt":"2024-12-04T13:13:47","slug":"elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\/","title":{"rendered":"Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division"},"content":{"rendered":"<div class=\"mw_release\">\n<ul type=\"disc\">\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong><br \/>\n            <em>Skincare Division Achieves New Sales Milestone, Enters Holiday Season with Strong Momentum<\/em><br \/>\n          <\/strong><br \/>\n          \n        <\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong><br \/>\n            <em>Strategic Restructuring Efforts Contributes to Achieving Record Monthly Sales and Sets Stage for Positive Projections for Year-End Growth<\/em><br \/>\n          <\/strong><br \/>\n          \n        <\/li>\n<\/ul>\n<p align=\"left\">NEWPORT BEACH, Calif., Dec.  04, 2024  (GLOBE NEWSWIRE) &#8212; <strong>Elevai Labs Inc.<\/strong> (Nasdaq: ELAB) (\u201cElevai\u201d, \u201cElevai Labs\u201d or the \u201cCompany\u201d), a diversified holding company, announces that its wholly owned subsidiary, Elevai Skincare Inc. (\u201cElevai Skincare\u201d), has achieved a record-breaking month in sales for 2024, marking a significant milestone for the Company. This achievement underscores the success of transformational restructuring efforts led by Elevai Labs\u2019 new executive team and the adoption of a performance-driven culture.<\/p>\n<p>The milestone comes as the Elevai Skincare division heads into the holiday season with strong momentum, strengthened by strategic initiatives that have streamlined operations, enhanced productivity, and positioned the brand for continued growth. Elevai\u2019s management expressed its appreciation for the hard work and dedication of the Elevai Skincare operations team and sales force, who have demonstrated resilience in adapting to the newly implemented performance-based culture.<\/p>\n<p>Since taking leadership of Elevai Labs, the parent company of Elevai Skincare, in the third quarter of 2024, the new management team has prioritized operational efficiency, strategic sales growth, and a high-performance sales culture. These efforts culminated in the highest monthly revenue figures for Elevai Skincare in 2024, exceeding the previous four months average sales by 65%, paving the way for strong year-end performance. The new management team\u2019s focus on cost management and strategic initiatives has delivered higher revenue while reducing operating expenses, reaffirming their commitment to operational improvements with a desire to reach positive\u00a0net\u00a0profits.<\/p>\n<p>\n        <strong>Key drivers of success include:<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>Sales Culture Transformation<\/strong>: Performance-based incentives and a results-oriented environment have driven motivation and accountability across the sales team.<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>Optimized Budgets and Marketing Strategies<\/strong>: Stringent budgeting and accountability measures have ensured efficient resource allocation. By prioritizing impactful campaigns, the sales team has strengthened relationships with core physician-dispensed channels and driven disciplined, sustainable growth.<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>Integrated Marketing and Sales Objectives<\/strong>: Improved collaboration between marketing and sales teams has aligned campaigns with sales goals, enhancing lead generation and conversion outcomes.<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>Targeted Training Programs<\/strong>: Comprehensive training programs for both the sales team and physician-dispensed customers have bolstered advanced product knowledge, improved patient recommendation strategies, and strengthened clinic partnerships.<\/li>\n<\/ul>\n<p>\n        <strong>Preliminary unaudited sales data for Elevai Skincare for November 2024<\/strong> reflects revenue of <strong>$300K <\/strong>significantly higher than monthly figures earlier in the year:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:5pt;margin-bottom:5pt\">July: $160K<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">August: $199K<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">September: $168K<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">October: $198K<\/li>\n<\/ul>\n<p>\n        <strong>Positioned for Continued Growth<\/strong><br \/>\n        <br \/>Elevai Skincare\u2019s strong performance aligns with the Company\u2019s overarching goal of creating shareholder value through operational excellence and strategic growth across its subsidiaries. With strong momentum entering the holiday season, the Company is well-positioned to drive further success as it closes out the year.<\/p>\n<p>\n        <strong>About Elevai Labs, Inc.<\/strong>\n      <\/p>\n<p>Elevai Labs Inc. (NASDAQ: ELAB) specializes in medical aesthetics and biopharmaceutical drug development, focusing on innovations for skin aesthetics and treatments tied to obesity and metabolic health. The Company operates a diverse portfolio of three wholly owned subsidiaries across the medical aesthetics and biopharmaceutical sectors, Elevai Skincare Inc., Elevai Biosciences Inc., and Elevai Research Inc. For more information please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8rbObVpTHYwdVWzHQzoTLc7JJpmLthlgd0FRDjhCqmAaXZTL10bCG5F2x9BuPrc9wcn9cNNoNC-Bo5LzCJEs3eqSjFqz6Y2pXgq9dYzyamCFUwhl2yy37CuLbeixkPU9w-LwMVNG14-6kwIhmQYhazpFBE_ugElLCCL6rNRmcovfvgEuIYF7XTF5cQ5fOq4nXqGbI92t0xyUwYeu15yBiOBJBsItWbvSidx-QA803x09eXP94rITo4cOcMUkZhqKKxpHN19BlNR4s2dt0dZe_WpW1xkXoQAS-EYP3NWPD1lvWpjVcPtEcpu_Hb5ttoNUx14j7tkGRG5Qc_65ZE9S8BE_2aAYvUV5ku-70_lNjI343eGi-DOhUHTYiw9CCoc_-cgM2H5d4IOWt6lIRiqUs_zZkxTa9lAasZ04HBAUoQwsLKerkkFi99N4KI3TiE-iAIfbRKkaorjUReZNEpo0KaNoQAdU6tKo5EZ0wQmmavc=\" rel=\"nofollow\" target=\"_blank\">www.elevailabs.com<\/a>.<\/p>\n<p>\n        <strong>About Elevai Skincare Inc.<\/strong>\n      <\/p>\n<p>\n        <strong>A<\/strong> subsidiary of Elevai, Elevai Skincare is a medical aesthetics company developing and commercializing cutting-edge physician-dispensed skin and hair care applications that focuses on science-backed applications for the physician-dispensed market, utilizing cutting-edge technologies to redefine skincare and hair care, including its stem cell exosome technology. For more information, please visit elevaiskincare.com.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p>Statements contained in this press release regarding matters that are not historical facts are \u201cforward-looking statements\u201d within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Words such as \u201cbelieves,\u201d \u201cexpects,\u201d \u201cplans,\u201d \u201cpotential,\u201d \u201cwould\u201d and \u201cfuture\u201d or similar expressions such as \u201clook forward\u201d are intended to identify forward-looking statements. Forward-looking statements are made as of the date of this press release and are neither historical facts nor\u00a0assurances of future performance. Instead, they are based only on our current beliefs,\u00a0expectations\u00a0and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, activities of regulators and future regulations and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results. Therefore, you should not rely on any of these forward-looking statements. These risks and uncertainties include, among others: Elevai\u2019s limited operating history and historical losses; Elevai\u2019s ability to raise additional funding to complete the development and any commercialization of its product candidates; Elevai\u2019s dependence on the success of its product candidates EL-22 and EL-32; that Elevai may be delayed in initiating, enrolling or completing any clinical trials; competition from third parties that are developing products for similar uses; Elevai\u2019s ability to obtain, maintain and protect its intellectual property; Elevai\u2019s dependence on third parties in connection with manufacturing, clinical trials and preclinical studies; and Elevai\u2019s expectations regarding its growth, strategy, progress and the design, objectives and timing of its studies.\u00a0These and other risks are described more fully in Elevai\u2019s filings with the United States Securities and Exchange Commission (\u201cSEC\u201d), including the \u201cRisk Factors\u201d section of the Company\u2019s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on March 29, 2024, and its other documents subsequently filed with or furnished to the SEC. Investors and security holders are urged to read these documents free of charge on the SEC\u2019s web site at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Jg10Cuwf_b4UuefLKCX_EsUdr15I85Y4xfaip6zi9TmCQ1RUU4owL7pYwQE7S5UjXdHeBGt3ZqtUhgDKo6r1Xd7B5KEYFpFaySc-M7dl1StpL0MHu-BlxDfD9cycOvdrIN6ci9p7wiMgzyQVGdu37J_Ta7zwElpl2D_Pcwx_u9hXHqF4GBCO3GJjPVcPkx0-wy6_bCpMnK8lwDQz7SEJqBEBZB1zTulJQkBkfKJGndUcN130XEn1bepHgTXxbm0l_TeuSOJPg8pCQFabx6MkztcAqAHPjq7eQg4AAXdkGvuL-DYm9tTwqLIW2Moq7mFcgNyxv79V962BHLSpmNZgLxklW0mNAE1PnAEqEP_RKSaoYTCPnodSsi6R5Acc-Sx4uBqVeGavI3FWsPD6dvX0O__tneK2pUaefFmHo1ZYt9E=\" rel=\"nofollow\" target=\"_blank\">www.sec.gov<\/a>. All forward-looking statements contained in this press release speak only as of the date on which they were made. Except to the extent required by law, the Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.<\/p>\n<p>IR Contact:<br \/>IR@ElevaiLabs.com<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMzg1NCM2NjIyMDg2IzIyNTg4MTI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NDAwMTM2NmUtN2FlYS00YTQ5LWE5MTItMTJlMDQ2MDk2ZTI3LTEyNzAzNjE=\/tiny\/Elevai-Labs-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Skincare Division Achieves New Sales Milestone, Enters Holiday Season with Strong Momentum Strategic Restructuring Efforts Contributes to Achieving Record Monthly Sales and Sets Stage for Positive Projections for Year-End Growth NEWPORT BEACH, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) &#8212; Elevai Labs Inc. (Nasdaq: ELAB) (\u201cElevai\u201d, \u201cElevai Labs\u201d or the \u201cCompany\u201d), a diversified holding company, announces that its wholly owned subsidiary, Elevai Skincare Inc. (\u201cElevai Skincare\u201d), has achieved a record-breaking month in sales for 2024, marking a significant milestone for the Company. This achievement underscores the success of transformational restructuring efforts led by Elevai Labs\u2019 new executive team and the adoption of a performance-driven culture. The milestone comes as the Elevai Skincare division heads into the holiday season with strong momentum, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-792316","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Skincare Division Achieves New Sales Milestone, Enters Holiday Season with Strong Momentum Strategic Restructuring Efforts Contributes to Achieving Record Monthly Sales and Sets Stage for Positive Projections for Year-End Growth NEWPORT BEACH, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) &#8212; Elevai Labs Inc. (Nasdaq: ELAB) (\u201cElevai\u201d, \u201cElevai Labs\u201d or the \u201cCompany\u201d), a diversified holding company, announces that its wholly owned subsidiary, Elevai Skincare Inc. (\u201cElevai Skincare\u201d), has achieved a record-breaking month in sales for 2024, marking a significant milestone for the Company. This achievement underscores the success of transformational restructuring efforts led by Elevai Labs\u2019 new executive team and the adoption of a performance-driven culture. The milestone comes as the Elevai Skincare division heads into the holiday season with strong momentum, &hellip; Continue reading &quot;Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-04T13:13:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMzg1NCM2NjIyMDg2IzIyNTg4MTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division\",\"datePublished\":\"2024-12-04T13:13:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\\\/\"},\"wordCount\":1037,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxMzg1NCM2NjIyMDg2IzIyNTg4MTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\\\/\",\"name\":\"Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxMzg1NCM2NjIyMDg2IzIyNTg4MTI=\",\"datePublished\":\"2024-12-04T13:13:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxMzg1NCM2NjIyMDg2IzIyNTg4MTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxMzg1NCM2NjIyMDg2IzIyNTg4MTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\/","og_locale":"en_US","og_type":"article","og_title":"Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division - Market Newsdesk","og_description":"Skincare Division Achieves New Sales Milestone, Enters Holiday Season with Strong Momentum Strategic Restructuring Efforts Contributes to Achieving Record Monthly Sales and Sets Stage for Positive Projections for Year-End Growth NEWPORT BEACH, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) &#8212; Elevai Labs Inc. (Nasdaq: ELAB) (\u201cElevai\u201d, \u201cElevai Labs\u201d or the \u201cCompany\u201d), a diversified holding company, announces that its wholly owned subsidiary, Elevai Skincare Inc. (\u201cElevai Skincare\u201d), has achieved a record-breaking month in sales for 2024, marking a significant milestone for the Company. This achievement underscores the success of transformational restructuring efforts led by Elevai Labs\u2019 new executive team and the adoption of a performance-driven culture. The milestone comes as the Elevai Skincare division heads into the holiday season with strong momentum, &hellip; Continue reading \"Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\/","og_site_name":"Market Newsdesk","article_published_time":"2024-12-04T13:13:47+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMzg1NCM2NjIyMDg2IzIyNTg4MTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division","datePublished":"2024-12-04T13:13:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\/"},"wordCount":1037,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMzg1NCM2NjIyMDg2IzIyNTg4MTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\/","name":"Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMzg1NCM2NjIyMDg2IzIyNTg4MTI=","datePublished":"2024-12-04T13:13:47+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMzg1NCM2NjIyMDg2IzIyNTg4MTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMzg1NCM2NjIyMDg2IzIyNTg4MTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elevai-labs-inc-announces-record-breaking-sales-month-in-2024-for-elevai-skincare-division\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/792316","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=792316"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/792316\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=792316"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=792316"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=792316"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}